177 related articles for article (PubMed ID: 10098728)
1. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
[TBL] [Abstract][Full Text] [Related]
2. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells.
de Jonge RR; Garrigue-Antar L; Vellucci VF; Reiss M
Oncol Res; 1997; 9(2):89-98. PubMed ID: 9167190
[TBL] [Abstract][Full Text] [Related]
3. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
Jakowlew SB; Mathias A; Chung P; Moody TW
Cell Growth Differ; 1995 Apr; 6(4):465-76. PubMed ID: 7794814
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
Shin KH; Park YJ; Park JG
Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
[TBL] [Abstract][Full Text] [Related]
5. Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung.
Kim WS; Park C; Jung YS; Kim HS; Han J; Park CH; Kim K; Kim J; Shim YM; Park K
Anticancer Res; 1999; 19(1A):301-6. PubMed ID: 10226558
[TBL] [Abstract][Full Text] [Related]
6. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta.
Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP
Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784
[TBL] [Abstract][Full Text] [Related]
8. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
Jakowlew SB; Moody TW; Mariano JM
Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
[TBL] [Abstract][Full Text] [Related]
10. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells.
Yang HK; Kang SH; Kim YS; Won K; Bang YJ; Kim SJ
Oncogene; 1999 Apr; 18(13):2213-9. PubMed ID: 10327067
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability(MSI) in non-small cell lung cancer(NSCLC) is highly associated with transforming growth factor-beta type II receptor(TGF-beta RII) frameshift mutation.
Kim WS; Park C; Hong SK; Park BK; Kim HS; Park K
Anticancer Res; 2000; 20(3A):1499-502. PubMed ID: 10928062
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of induction of transforming growth factor-beta type II receptor gene expression by v-Src in murine myeloid cells.
Park SH; Birchenall-Roberts MC; Yi Y; Lee BI; Lee DK; Bertolette DC; Fu T; Ruscetti F; Kim SJ
Cell Growth Differ; 2001 Jan; 12(1):9-18. PubMed ID: 11205746
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
[TBL] [Abstract][Full Text] [Related]
14. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
[TBL] [Abstract][Full Text] [Related]
15. Effect of ets-related transcription factor (ERT) on transforming growth factor (TGF)-beta type II receptor gene expression in human cancer cell lines.
Lee HJ; Chang JH; Kim YS; Kim SJ; Yang HK
J Exp Clin Cancer Res; 2003 Sep; 22(3):477-80. PubMed ID: 14582709
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
[TBL] [Abstract][Full Text] [Related]
17. A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
Tanaka S; Mori M; Mafune K; Ohno S; Sugimachi K
Br J Cancer; 2000 May; 82(9):1557-60. PubMed ID: 10789724
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
Kang SH; Bang YJ; Im YH; Yang HK; Lee DA; Lee HY; Lee HS; Kim NK; Kim SJ
Oncogene; 1999 Dec; 18(51):7280-6. PubMed ID: 10602482
[TBL] [Abstract][Full Text] [Related]
19. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]